GYNAECOLOGY CANCER RESEARCH FUND
Get an alert when GYNAECOLOGY CANCER RESEARCH FUND files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£1.1m
+2% highest in 3 filed years
Net assets
£586k
-25.1% lowest in 3 filed years
Employees
17
-5.6% lowest in 3 filed years
Profit before tax
-£197k
-295.6% vs 2024
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Total income | £87,901 | £1,782,838 | £1,729,124 | -3% | |
| Operating profit | — | — | — | — | |
| Profit before tax | — | £100,584 | -£196,743 | -295.6% | |
| Net profit | -£255,422 | £100,584 | -£196,743 | -295.6% | |
| Cash | £928,895 | £1,060,129 | £1,081,311 | +2% | |
| Total assets less current liabilities | £681,787 | £782,371 | £585,628 | -25.1% | |
| Net assets | £681,787 | £782,371 | £585,628 | -25.1% | |
| Equity | £681,787 | £782,371 | £585,628 | -25.1% | |
| Average employees | 20 | 18 | 17 | -5.6% | |
| Wages | £722,297 | £718,591 | £711,141 | -1% | |
| Directors' remuneration | — | £0 | £0 | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Net margin | — | 5.6% | -11.4% | |
| Gearing (liabilities / total assets) | 40.7% | 39.0% | 55.3% | |
| Current ratio | 2.40x | 2.52x | 1.77x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Moore Kingston Smith LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Trustees believe that the Charity is well placed to manage operational and financial risks successfully. Accordingly, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operation for the foreseeable future and consider that there are no material uncertainties about the group's ability to continue as a going concern.”
Group structure
- GYNAECOLOGY CANCER RESEARCH FUND · parent
- Eve Appeal Limited 100%
- Sola Diagnostics GMBH
Significant events
- “In 2025 we launched phase two focusing on recognising ovarian cancer symptoms and promoting early diagnosis, which can save lives. The second phase was launched at local nail salons, offering the opportunity to engage with local women, share vital resources, and invite them to receive a limited number of free, signature You Need to Know manicures, designed to spark conversations and raise awareness.”
- “This year we set out to provide practical advice and support to help make cervical screening easier and more accessible, empowering more people to attend their appointments with confidence. Across the week our organic social media channels, Meta adverts, Google Pay per click ads, and email reached over 714,000 people.”
- “This Ovarian Cancer Awareness Month we re-launched our rare ovarian cancer webpages and shared information on ovarian cancer- its symptoms, risk factors and the rarer forms. Our organic social media reached over 203,300 on Instagram and Facebook.”
- “This Get Lippy we shared our tips for gynae health appointments. Our YouGov survey found that 1 in 3 women had put off getting gynae symptoms checked out. 1 in 3 said they felt nervous or uncomfortable talking about gynae health with a doctor and 1 in 4 have felt embarrassed.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
10 active · 32 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| COSEC DIRECT LIMITED | Corporate Secretary | 2009-10-29 | — | — |
| BAILEY, Sally Frances | Director | 2023-10-18 | Dec 1965 | British |
| BOX, Mary Tamara | Director | 2020-07-01 | Sep 1967 | American,British |
| BYRNE, Katharine Helen | Director | 2025-02-05 | Jan 1956 | British |
| DEAN, Emma | Director | 2023-10-18 | Mar 1989 | British |
| EKECHI, Christine, Dr | Director | 2020-10-26 | May 1980 | British |
| JACOBS, Ian Jeffrey, Professor | Director | 2022-05-29 | Oct 1957 | British,Australian |
| MORRIS, Sarah Louise | Director | 2019-12-19 | Aug 1978 | British |
| O'HARA, Marion Rachel | Director | 2021-10-27 | Nov 1959 | British |
| ROSENTHAL, Adam, Prof. | Director | 2020-10-26 | Jan 1968 | British |
Show 32 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DOVE, Anthony Charles | Secretary | 2002-02-08 | 2009-10-29 |
| ANDERSON, Lisa Deborah, Dr | Director | 2018-04-06 | 2019-11-04 |
| ANDERSON, Moreen Ruth | Director | 2006-03-15 | 2012-04-02 |
| BAILEY, Sally Frances | Director | 2014-06-27 | 2019-11-04 |
| BLOOMER, Anne Elizabeth Judith | Director | 2015-12-10 | 2022-06-21 |
| BRECKER, Deirdre Rosa | Director | 2023-10-18 | 2025-01-23 |
| CLARK, Sarah Frances | Director | 2019-11-04 | 2026-02-04 |
| DOVE, Anthony Charles | Director | 2002-02-08 | 2009-10-29 |
| DREW, Ian Ashley | Director | 2016-09-29 | 2025-02-05 |
| FITZGIBBONS, Alexander Seamus | Director | 2009-10-22 | 2017-06-19 |
| FLEMING, Caroline Elisabeth Ada, Baroness | Director | 2003-06-17 | 2011-09-21 |
| GERVASIO, Emma Jennifer | Director | 2014-03-28 | 2019-11-04 |
| JACOBS, Ian Jeffrey, Professor | Director | 2013-06-20 | 2014-12-12 |
| JACOBS, Ian Jeffrey, Prof. | Director | 2002-02-08 | 2003-07-09 |
| KINGSMILL, Sidonie | Director | 2016-09-29 | 2024-01-25 |
| LEONARD, Jennifer Mary | Director | 2015-12-10 | 2023-11-17 |
| MACLENNAN, Angus Gillies | Director | 2002-02-08 | 2019-12-19 |
| MILLER, Carla | Director | 2015-12-10 | 2016-03-02 |
| MORRISSEY, Helena Louise, Baroness | Director | 2012-09-26 | 2015-10-01 |
| OLAITAN, Adeola, Dr | Director | 2016-09-29 | 2019-11-04 |
| ORAM, David Howard | Director | 2002-02-12 | 2016-09-29 |
| PRITCHARD, Kathleen Johanna | Director | 2021-10-27 | 2023-02-20 |
| RICHARDS, Melanie Jane | Director | 2010-01-14 | 2024-02-07 |
| SHARMAN OF REDLYNCH, Colin, Lord | Director | 2005-10-01 | 2012-09-26 |
| SILVERSTONE, Anthony Charles, Dr | Director | 2004-01-12 | 2016-09-29 |
| TAN, Lay Koon | Director | 2019-11-04 | 2022-06-07 |
| TROEN, Per | Director | 2009-10-22 | 2014-09-30 |
| VAGN JENSEN, Peter | Director | 2002-02-12 | 2014-03-28 |
| WATSON, Clive Royston | Director | 2016-09-29 | 2017-04-25 |
| WATTS, Anne Margaret | Director | 2005-10-31 | 2017-10-30 |
| WATTS, Anne Margaret | Director | 2003-07-01 | 2005-03-26 |
| WILEY, Catherine Alice | Director | 2019-11-04 | 2026-02-04 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 191 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-04 | AA | accounts | Accounts with accounts type group | |
| 2026-06-23 | AP01 | officers | Appoint person director company with name date | |
| 2026-05-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-02-23 | TM01 | officers | Termination director company with name termination date | |
| 2026-02-23 | TM01 | officers | Termination director company with name termination date | |
| 2025-09-15 | AA | accounts | Accounts with accounts type group | |
| 2025-08-22 | CH01 | officers | Change person director company with change date | |
| 2025-06-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-03 | CH01 | officers | Change person director company with change date | |
| 2025-06-02 | RP04AP01 | officers | Second filing of director appointment with name | |
| 2025-06-02 | CH01 | officers | Change person director company with change date | |
| 2025-06-02 | CH01 | officers | Change person director company with change date | |
| 2025-05-31 | CH01 | officers | Change person director company with change date | |
| 2025-05-31 | CH01 | officers | Change person director company with change date | |
| 2025-03-19 | AP01 | officers | Appoint person director company with name date | |
| 2025-03-19 | TM01 | officers | Termination director company with name termination date | |
| 2025-03-19 | TM01 | officers | Termination director company with name termination date | |
| 2024-08-30 | AA | accounts | Accounts with accounts type group | |
| 2024-05-31 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-31 | CH01 | officers | Change person director company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.